April 27, 2016
The Medicare Part B payment demonstration planned by the Centers for Medicare and Medicaid Services lacks a vital component: a clear strategy for monitoring the experiment’s effect on patient care.
April 8, 2016
Patients with respiratory conditions are often not sick enough to be in critical care but not well enough to deal with their symptoms without consistent intervention. So explains a newly released white paper from the Institute for Patient Access and the Alliance for Patient Access’ Respiratory Therapy Access Working Group.
March 8, 2016
Research recently published in the New England Journal of Medicine confirms the mosquito-borne Zika virus’ danger for pregnant women.
March 1, 2016
The first anniversary of the White House’s Precision Medicine Initiative gave participants time to reflect on the year’s progress – and contemplate the challenges ahead.
February 16, 2016
The Food and Drug Administration could soon approve a complex biosimilar to treat eight disease states and patient groups – even though clinical testing data has been submitted for only two.
January 28, 2016
January 26 ended the public comment period for the U.S. Senate Finance Committee’s chronic care working group policy options paper—cueing the group’s legislative efforts to begin in earnest.
October 22, 2015
The federal government’s 1990s “Share your life. Share your decision.” awareness campaign capitalized on endorsements from the likes of Michael Jordan to increase organ donor registrations nationwide.
October 1, 2015
By Alan Marks, MD, and Mary Ann Chapman, PhD Despite major advances in cancer medicine (oncology), cancer remains a deadly…
July 30, 2015
The National Lieutenant Governors Association has a message for citizens who want to see cures for Alzheimer’s, cancer, diabetes and other conditions: Participate in clinical trials.
May 7, 2015
It’s Clinical Trials Awareness Week. And as patients, health care providers, researchers and industry promote the value of clinical trials participation, one coalition is asking the federal government to help solve clinical trials’ chronic under-enrollment.
